BridgeMD
Compares treatment options for Difficult Intravenous Access
Official title Single Lumen Midline Catheter vs Long Peripheral Intravenous Cather for Difficult Intravenous Access in the ED
ClinicalTrials.gov ID: NCT06668766
What this study is testing
- What it's testing
- Many patients in the emergency department have veins that are difficult to get an intrevenous (IV) catheter into (called "difficult IV access"). These patients may require other methods to obtain access to a vein for administration of the necessary medications.
- Time commitment: about 24 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult (age 18 and older) patients presenting to the AMC ED with difficult IV access defined as any of the following:
- Two failed attempts at landmark based IV or US-guided peripheral vascular access by qualified ED staff
- Self-reported history of difficult IV access and one of the following:
- History of requiring 2 or more IV attempts on a previous visit (either self-reported or documented in the electronic medical record)
- Previous requirement for a rescue device after failed IV access attempt. These devices are as follows:
You likely can't join if
- Patients under the age of 18
- Known Prisoners
- Non-English-speaking patients
- Patients in whom the device cannot be stabilized due to tissue or treatments in bilateral extremities or available extremity (burns, complex humeral...
- Patients lacking capacity to consent
- Patients unable to sign written consent
See the full eligibility criteria
- Adult (age 18 and older) patients presenting to the AMC ED with difficult IV access defined as any of the following:
- Two failed attempts at landmark based IV or US-guided peripheral vascular access by qualified ED staff
- Self-reported history of difficult IV access and one of the following:
- History of requiring 2 or more IV attempts on a previous visit (either self-reported or documented in the electronic medical record)
- Previous requirement for a rescue device after failed IV access attempt. These devices are as follows:
- US guided PIV
- Midline catheter
- Peripherally inserted central catheter
- Central venous catheter
- Intraosseous catheter
- History of or active comorbid disease state with known difficult IV access
- Prior or current implanted port device
- End stage renal disease with fistula
- Sickle cell disease
- History of or active intravenous drug use
- Patients under the age of 18
- Known Prisoners
- Non-English-speaking patients
- Patients in whom the device cannot be stabilized due to tissue or treatments in bilateral extremities or available extremity (burns, complex humeral fractures, dialysis fistulas etc.)
- Patients lacking capacity to consent
- Patients unable to sign written consent
- Patients without identifiable target veins by ultrasonography
- Known pregnant patients
- Previously enrolled in this study
- Previously withdrawn from this study
- Presented when no study IV proceduralists are available
- Patients in whom obtaining informed consent and being enrolled in the study would put them at risk for obtaining time sensitive medical care
The study team makes the final eligibility decision.
Where it's taking place
- Albany, New York, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 24 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Albany, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.